Through the inhibition of Smad-1 and p38/MAPK, reduced bone morphogenetic protein (BMP) signaling resulted in greater proliferation of hPASMCs, one of the major causes of PAH. Here, SMAD1 is linked to pulmonary arterial hypertension.